Results 81 to 90 of about 1,633 (196)

Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of peritoneal metastases

open access: yes, 2019
Pressurised intraperitoneal aerosol chemotherapy (PIPAC) was introduced in Denmark in 2015. More than 100 Danish patients with peritoneal metastases (PM) have received PIPAC-directed treatment within the PIPAC-OPC1 and PIPAC-OPC2 trials.
Ør Knudsen, Anja   +5 more
core  

Read counts Constantinides RNASeq PIPAC study

open access: yes
<p>Read counts Constantinides RNASeq PIPAC study</p ...
Kranenburg, Onno
core   +1 more source

Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases - a systematic review

open access: yes, 2021
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) is increasingly used as a palliative treatment option for patients with colorectal peritoneal metastases (CPM).
Creemers, G.J.   +11 more
core   +1 more source

Pressurized intraperitoneal aerosol chemotherapy in advanced colorectal cancer with peritoneal metastases: a meta-analysis of feasibility, efficacy, and safety

open access: yesHolistic Integrative Oncology
Background Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has emerged as a promising therapeutic approach for treating advanced colorectal cancer with peritoneal metastases.
Ruijian Chen   +3 more
doaj   +1 more source

Intraperitonealna aerosolna kemoterapija pod povišanim pritiskom

open access: yesOnkologija, 2019
Bolniki s peritonealnimi metastazami imajo kljub multimodalnemu zdravljenju s kirurgijo in kemoterapijo slabo prognozo. Samo citoreduktivna kirurgija  je lahko kurativna pri zdravljenju peritonealne karcinoze, toda le manjši delež bolnikov je primeren za
Erik Brecelj   +3 more
doaj   +1 more source

Intraperitoneale Druck-Aerosol-Chemotherapie (PIPAC) als zusätzliches Therapieelement bei Patienten mit fortgeschrittener Peritonealkarzinose

open access: yes, 2019
PIPAC als zusätzliches Therapieelement bei Patienten mit Peritonealkarzinose. Ziel dieser Studie ist es, das Überleben, die klinischen Merkmale, die Tumorhistologie und das Ausmaß der Erkrankung von Pat.
Girshally, Ramy
core   +1 more source

Multivisceral resection for ovarian cancer with peritoneal carcinomatosis following induction bidirectional chemotherapy using pressurized intraperitoneal aerosol chemotherapy

open access: yesЮжно-Российский онкологический журнал
Peritoneal carcinomatosis in advanced ovarian cancer is an unfavorable prognostic factor and limits the efficacy of systemic chemotherapy. This provides a rationale for the use of locoregional treatment modalities, including pressurized intraperitoneal ...
A. S. Dzasokhov   +6 more
doaj   +1 more source

Pressurized intraperitoneal aerosol chemotherapy: a review of the introduction of a new surgical technology using the IDEAL framework

open access: yesBJS Open, 2020
Background The IDEAL (Idea, Development, Evaluation, Assessment, Long‐term study) framework is a scheme of investigation for innovative surgical therapeutic interventions.
S. J. Tate, J. Torkington
doaj   +1 more source

PIPAC may work but more data is needed [PDF]

open access: yesJournal of Gastrointestinal Oncology, 2021
Paul H, Sugarbaker   +1 more
openaire   +2 more sources

Review on treatment of pleural metastasis and malignant pleural effusion with Pressurized IntraThoracic Aerosol Chemotherapy (PITAC)

open access: yesPleura and Peritoneum
Malignant pleural effusion (MPE) is a common and debilitating condition seen in advanced cancer disease, and life-expectancy is short. Symptoms include pain and severe shortness of breath.
Hansen Pernille Schjødt   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy